1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

First!

Discussion in 'Medacta' started by anonymous, Jul 15, 2016 at 1:48 PM.

  1. anonymous

    anonymous Guest

    How are the ex-Zimmer guys doing in Western NC with the Medacta bag? Seems like some cool gadgets this company has.
     
  2. anonymous

    anonymous Guest

    I really like their medial pivot knee the Sphere. I was convinced that when Depuy bought Finsbury a couple of years ago that it was for their MRK knee. I was stunned that when the Attune broke cover that it was just a conventional design.
     
  3. anonymous

    anonymous Guest

    I really like their medial pivot knee the Sphere. I was convinced that when Depuy bought Finsbury a couple of years ago that it was for their MRK knee. I was stunned that when the Attune broke cover that it was just a conventional design.
     
  4. anonymous

    anonymous Guest

    It is easy to convert when you can just pay them.
     
  5. anonymous

    anonymous Guest

    What they pay docs is freely viewable on the sunshine site - and it's actually a lot less than some other companies.

    If you want to pretend to yourself that's how they get business, go ahead - but it's just not......
     
  6. anonymous

    anonymous Guest

    All that is reported might not actually be the whole truth...plus, the surgeons getting paid are not big names that other companies would want. Still, some cool products, and no need to pay docs or hire relatives of docs to succeed.
     
  7. anonymous

    anonymous Guest

    I love these boards, so full of inaccuracies. Medacta did not buy Finsbury. Who in their right mind would think their Sunshine data is false? Must be reps who can't compete and are looking for lame excuses. Believe me, with all the industry consolidation there are plenty of solid reps looking for great opportunities and leaving to take business from the hangers on who have managed to leach onto this great industry. Go sell something and stop making excuses and blaming others.
     
  8. anonymous

    anonymous Guest

    Who said Medacta bought Finsbury? Read carefully and you will see it was Depuy not Medacta.
     
  9. anonymous

    anonymous Guest